论文部分内容阅读
2008年末,美国陆军宣布放弃以ARH -70A作为新型武装侦察直升机的研发计划,这是继2004年宣布撤销总金额为146亿美元的RAH-66“科曼奇”轻型侦察/攻击直升机研发计划后,美军在陆航装备发展上进行的又一项重大调整。消息传出后,媒体一片哗然。刚刚被定为新装备研发计划的ARH-70A转眼之间就下马,这其中到底有什么玄机,美军葫芦里到底卖着什么药,让我们以此文一探究竟。
In late 2008, the U.S. Army announced the abandonment of the R & D program of the ARH-70A as a new type of armed reconnaissance helicopter. Following the announcement in 2004 of the revocation of RAH-66 Light Coach Reconnaissance / Attack Helicopter with a total value of 14.6 billion U.S. dollars After the plan, the U.S. military made another major adjustment in the development of its air equipment. After the news came out, the media was in an uproar. ARH-70A, which has just been designated as a new equipment research and development program, was launched in an instant. What exactly is this mystery and what drugs are sold in the U.S. military gourd? Let us explore this article.